Rapid-sequence intubation and the role of the emergency department pharmacist

American Journal of Health-System Pharmacy

Volumn 68, Issue 14, 2011, Pages 1320-1330

  Hampton, Jeremy P ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b TRUMAN MEDICAL CENTER   (United States)

Author keywords

Anesthesia; Anesthetics; Anesthetics, local; Anxiolytics, sedatives and hypnotics; Dosage; Etomidate; Fentanyl; Hospitals; Intubation; Ketamine; Lidocaine; Midazolam; Neuromuscular blocking agents; Opiates; Pharmaceutical services; Pharmacists, hospital; Rocuronium; Succinylcholine; Thiopental; Toxicity

Indexed keywords

AMIODARONE; ATRACURIUM; ATROPINE; BENZODIAZEPINE; DOFETILIDE; ETOMIDATE; FENTANYL; LIDOCAINE; METHOHEXITAL; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; PANCURONIUM; PANCURONIUM BROMIDE; PROPOFOL; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; TUBOCURARINE CHLORIDE; VECURONIUM;

ANESTHESIA INDUCTION; BRADYCARDIA; BRAIN PERFUSION; EMERGENCY CARE; EMERGENCY MEDICINE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; HUMAN; HYPOTENSION; INTRACRANIAL PRESSURE; LARYNGOSCOPY; PHARMACIST; PREMEDICATION; PRIORITY JOURNAL; RAPID SEQUENCE INTUBATION; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE;

EID: 79960652642     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100437     Document Type: Review

References (127)

1. Szczesiul JM, Fairbanks RJ, Hildebrand JM et al. Survey of physicians regarding clinical pharmacy services in academic emergency departments. Am J Health-Syst Pharm. 2009; 66:576-9.
2. Hospital-based emergency care: at the breaking point. Washington, DC: National Academies Press; 2006.
3. Mace E. Challenges and advances in intubation: rapid sequence intubation. Emerg Med Clin North Am. 2008; 26:1043-68.
4. Walls RM. Rapid sequence intubation. In: Walls RM, Murphy MF, eds. Emergency airway management. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008:23-35.
5. Wadbrook PS. Advances in airway pharmacology. Emerg Med Clin North Am. 2000; 18:767-88.
6. Caro DA, Bush S. Pretreatment agents. In: Walls RM, Murphy MF, eds. Emergency airway management. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008:222-33.
7. Danzl DF, Vissers RJ. Tracheal intubation and mechanical ventilation. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency medicine: a comprehensive study guide. 6th ed. New York: McGraw-Hill; 2004:108-19.
8. Clancy M, Halford S, Walls R et al. In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review. Emerg Med J. 2001; 18:373-5. (Pubitemid 34070968)
9. Martin R, Carrier J, Pirlet M et al. Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia. Can J Anaesth. 1998; 45:521-5. (Pubitemid 28372265)
10. Eisenkraft J, Mingus ML, Book WJ et al. A defasciculating dose of D-tubocurarine causes resistance to succinylcholine. Can J Anaesth. 1990; 37: 538-42. (Pubitemid 20223336)
11. Lidocaine hydrochloride package insert. Lake Forest, IL: Hospira, Inc.; 2004.
12. Lidocaine. In: DRUGDEX System [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc. Updated periodically.
13. DRUG-REAX System [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc. Updated periodically.
14. Donegan MF, Bedford RF. Intravenously administered lidocaine prevents intracranial hypertension during endotracheal suctioning. Anesthesiology. 1980; 52:516-8. (Pubitemid 10114446)
15. Shapiro HM, Wyte SR, Harris AB et al. Acute intraoperative hypertension in neurosurgical patients. Mechanical and pharmacologic factors. Anesthesiology. 1972; 37:399-405.
16. Aouad MD, Sayyid SS, Zalaket MI et al. Intravenous lidocaine as adjuvant to sevoflurane anesthesia for endotracheal intubation in children. Anesth Analg. 2003; 96:1325-7. (Pubitemid 36512869)
17. Davidson JA, Gillsepie JA. Tracheal intubation after induction of anaesthesia with propofol, alfentanil and IV lignocaine. Br J Anaesth. 1993; 70:163-6. (Pubitemid 23042089)
18. Jakobsen CJ, Ahlburg P, Holdgard HO et al. Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia. Acta Anaesthesiol Scand. 1991; 35:238-41.
19. Lin CS, Sun WZ, Chan WH et al. Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough. Can J Anaesth. 2004; 51:654-9.
20. Nishino T, Hiraga K, Sugimori K. Effects of IV lignocaine on airway reflexes elicited by irritation of the tracheal mucosa in humans anaesthetized with enflurane. Br J Anaesth. 1990; 64:682-7. (Pubitemid 20201426)
21. Pandey CK, Raza M, Ranjan R et al. Intravenous lidocaine suppresses fentanylinduced coughing: a double-blind, prospective, randomized placebo-controlled study. Anesth Analg. 2004; 99:1696-8. (Pubitemid 39551905)
22. Pandey CK, Raza M, Ranjan R et al. Intravenous lidocaine 0.5 mg.kg-1 effectively suppresses fentanyl-induced cough. Can J Anaesth. 2005; 52:172-5. (Pubitemid 40467975)
23. Warner LO, Balch DR, Davidson PJ. Is intravenous lidocaine an effective adjuvant for endotracheal intubation in children undergoing induction of anesthesia with halothane-nitrous oxide? J Clin Anesth. 1997; 9:270-4. (Pubitemid 27264154)
24. Yukioka H, Hayashi M, Terai T et al. Intravenous lidocaine as a suppressant of coughing during tracheal intubation in elderly patients. Anesth Analg. 1993; 77:309-12. (Pubitemid 23221430)
25. Robinson N, Clancy M. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to improved neurological outcome? A review of the literature. Emerg Med J. 2001; 18:453-7. (Pubitemid 34071001)
26. Walls RM. Lidocaine and rapid squence intubation. Ann Emerg Med. 1996; 27:528-9.
27. Gal T. Bronchial hyperresponsiveness and anesthesia: physiologic and therapeutic perspectives. Anesth Analg. 1994; 78:559-73. (Pubitemid 24079384)
28. Gold M. Anesthesia, bronchospasm, and death. Semin Anesth. 1989; 8:291-306. (Pubitemid 20039945)
29. Grueben H, Foster W, Brown R. Intravenous lidocaine and oral mexilitive block reflex bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med. 1997; 156:1703-4. (Pubitemid 27505548)
30. Grueben H, Silvanus M, Beste M et al. Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations. Am J Respir Crit Care Med. 1999; 159:530-5. (Pubitemid 29084877)
31. Downes H, Gerber N, Hirshman C. IV lignocaine in reflex and allergic bronchoconstriction. Br. J Anesth. 1980; 52:873-80.
32. Nelson BP, Jagoda AS. Reactive airway disease. In: Walls RM, Murphy MF, eds. Emergency airway management. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2008:351-60.
33. Fentanyl citrate package insert. Deerfield, IL: Baxter Healthcare Corporation; 2009.
34. Chung KS, Sinatra RS, Halevy JD et al. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction. Can J Anaesth. 1992; 38:774-9.
35. Cork RC, Weiss JL, Hameroff SR et al. Fentanyl preloading for rapid-sequence induction of anesthesia. Anesth Analg. 1984; 63:60-4. (Pubitemid 14216413)
36. Dahlgren N, Messeter K. Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia. 1981; 36:1022-6. (Pubitemid 12237633)
37. Caspi J, Klausner JM, Safadi T et al. Delayed respiratory depression following fentanyl anesthesia for cardiac surgery. Crit Care Med. 1988; 16:238-40. (Pubitemid 18081903)
38. Atropine sulfate package insert. Lake Forest, IL: Hospira, Inc.; 2004.
39. Thiopental sodium package insert. Lake Forest, IL: Hospira, Inc.; 2004.
40. Brevital sodium (methohexital sodium) package insert. Rochester, MI: JHP Pharmaceuticals; 2009.
41. Caro DA, Tyler KR. Sedative induction agents. In: Walls RM, Murphy MF, eds. Manual of emergency airway management. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008:235-47.
42. Sagarin MJ, Barton ED, Sakles JC et al. Underdosing of midazolam in emergency endotracheal intubation. Acad Emerg Med. 2003; 10:329-38. (Pubitemid 36437790)
43. Midazolam package insert. Lake Forest, IL: Hospira, Inc.; 2009.
44. Etomidate package insert. Lake Forest, IL: Hospira, Inc.; 2004.
45. Lundy JB, Slane ML, Frizzi JD. Acute adrenal insufficiency after a single dose of etomidate. J Intensive Care Med. 2007; 22:111-7. (Pubitemid 46548132)
46. Den Brinker M, Hokken-Koelega AC, Hazelzet JA et al. One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis. Intensive Care Med. 2008; 34:163-8.
47. Den Brinker M, Joosten KF, Liem O et al. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab. 2005; 90:5110-7. (Pubitemid 41262261)
48. Hildreth AN, Mejia VA, Maxwell RA et al. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma. 2008; 65:573-9.
49. Malerba G, Romano-Girard F, Cravoisy A et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med. 2005; 31:388-92.
50. Mohammad Z, Afessa B, Finkielman JH. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care. 2006; 10:R105.
51. Schenarts CL, Burton JH, Riker RR. Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med. 2001; 8:1-7. (Pubitemid 32057921)
52. Duthie DJ, Fraser R, Nimmo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth. 1985; 57:156-9. (Pubitemid 15093403)
53. Vinclair M, Broux C, Faure P et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008; 34:714-9. (Pubitemid 351660088)
54. Jackson WJ. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? A critical appraisal. Chest. 2005; 127:1031-8.
55. Hohl CM, Kelly-Smith CH, Yeung TC et al. The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med. 2010; 56:105-13.
56. Edwin SB, Walker PL. Controversies surrounding the use of etomidate for rapid sequence intubation in patients with suspected sepsis. Ann Pharmacother. 2010; 44:1307-13.
57. Tekwani KL, Watts HF, Sweis RT et al. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Ann Emerg Med. 2010; 56:481-9.
58. Zed PJ, Mabasa VH, Slavik RS et al. Etomidate for rapid sequence intubation in the emergency department: is adrenal suppression a concern? CJEM. 2006; 8:347-50. (Pubitemid 44608321)
59. Annane D, Sebille V, Carpentier C et al. Effect of treatment with low doses of hydrocortisone and fludricortisone on mortality in patients with septic shock. JAMA. 2002; 288:862-71.
60. Ray DC, McKeown DW. Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care. 2007; 11:R56.
61. Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology. 1984; 61:616-8. (Pubitemid 15201260)
62. Ebrahim ZY, DeBoer GE, Luders H et al. Effect of etomidate on the electroencephalogram of patients with epilepsy. Anesth Analg. 1986; 65:1004-6. (Pubitemid 16031302)
63. Reddy RV, Moorthy SS, Dierdorf SF et al. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg. 1993; 77:1008-11. (Pubitemid 23319801)
64. Krieger W, Coopermen J, Laxer KD. Seizures with etomidate anesthesia. Anesth Analg. 1985; 64:1226-7. Letter.
65. Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med. 1997; 15:221-30. (Pubitemid 27194129)
66. Ghoneim MM, Yamada T. Etomidate: a clinical and electroencephalographic comparison with thiopental. Anesth Analg. 1977; 56:479-85. (Pubitemid 8159466)
67. Vissers RJ. Prolonged seizure activity. In: Walls RM, Murphy MF, eds. Manual of emergency airway management. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008:385-90.
68. Ketamine hydrochloride package insert. Lake Forest, IL: Hospira, Inc.; 2005.
69. Wagner BK, O'Hara DA, Hammond JS. Drugs for amnesia in the ICU. Am J Crit Care. 1997; 6:192-201. (Pubitemid 127457724)
70. White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology. 1982; 56:119-36. (Pubitemid 12164876)
71. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth. 1996; 77:441-4. (Pubitemid 26341027)
72. Massopust LC Jr, Wolin LR, Albin MS et al. Electrophysiologic and behavioral responses to ketamine hydrochloride in the rhesus monkey. Anesth Analg. 1972; 51:329-41.
73. Sparks DL, Corssen G, Aizenman B et al. Ketamine-induced anesthesia: neural mechanisms in the rhesus monkey. Anesth Analg. 1973; 52:288-97.
74. Sparks DL, Corssen G, Aizenman B et al. Further studies of the neural mechanisms of ketamine-induced anesthesia in the rhesus monkey. Anesth Analg. 1975; 54:189-95.
75. Kitahata LM, Taub A, Kosaka Y. Lamina-specific suppression of dorsal-horn unit activity by ketamine hydrochloride. Anesthesiology. 1973; 38:4-11.
76. Tang AH, Schroeder LA. Spinal cord depressant effects of ketamine and etoxadrol in the cat and the rat. Anesthesiology. 1973; 39:37-43.
77. Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology. 1972; 37:613-9.
78. Traber DL, Wilson RD, Priano LL. Differentiation of the cardiovascular effects of CI-581. Anesth Analg. 1968; 47:769-78.
79. Schwartz DA, Horwitz LD. Effects of ketamine on left ventricular performance. J Pharmacol Exp Ther. 1975; 194:410-4.
80. Lundy PM, Gowdy CW, Colhoun EH. Tracheal smooth muscle relaxant effect of ketamine. Br J Anaesth. 1974; 46:333-6.
81. Nelson BP, Jagoda AS. Special clinical circumstances: reactive airway disease. In: Walls RM, Murphy MF, eds. Manual of emergency airway management. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008:351-60.
82. Shapiro HM, Wyte SR, Harris AB. Ketamine anaesthesia in patients with intracranial pathology. Br J Anaesth. 1972; 44:1200-4.
83. Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology. 1972; 36:69-75.
84. Kolenda H, Gremmelt A, Rading S et al. Ketamine for analgosedative therapy in intensive care treatment of head injured patients. Acta Neurochir. 1996; 138:1193-9. (Pubitemid 26355814)
85. Albanese J, Arnaud S, Rey M et al. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology. 1997; 87:1328-34. (Pubitemid 28007328)
86. Schreiber MA, Noriaki A, Scott BG et al. Determinants of mortality in patients with severe blunt head injury. Arch Surg. 2002; 137:285-90. (Pubitemid 34207987)
87. Bourgoin A, Albanese J, Wereszczynski N et al. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med. 2003; 31:711-7. (Pubitemid 36379573)
88. Langsjo JW, Kaisti KK, Aalto S et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003; 99:614-23. (Pubitemid 37051976)
89. Bourgoin A, Albanese J, Leone M et al. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med. 2005; 33:1109-13. (Pubitemid 40638187)
90. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg. 2005; 101:524-34. (Pubitemid 41045240)
91. Propofol package insert. Schaumburg, IL: APP Pharmaceuticals, LLC; 2009.
92. Lepage JY, Pinaud ML, Helias JH et al. Left ventricular performance during propofol of methohexital anesthesia: isotopic and invasive cardiac monitoring. Anesth Analg. 1991; 73:3-9.
93. Claeys MA, Gepts E, Camu F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth. 1988; 60:3-9. (Pubitemid 18053008)
94. Boer F, Ros P, Bovill JG et al. Effect of propofol on peripheral vascular resistance during cardiopulmonary bypass. Br J Anaesth. 1990; 65:184-9. (Pubitemid 20244565)
95. Grounds RM, Twigley AJ, Carli F et al. The haemodynamic effects of intravenous induction. Anaesthesia. 1985; 40:735-40.
96. Mulier JP, Wouters PF, Van Aken H et al. Cardiodynamic effects of propofol in comparison with thiopental: assessment with a transesophageal echocardiographic approach. Anesth Analg. 1991; 72:28-35.
97. Coetzee A, Fourie P, Coetzee J et al. Effect of various propofol plasma concentrations on regional myocardial contractility and left ventricular afterload. Anesth Analg. 1989; 69:473-83. (Pubitemid 20037370)
98. Gelissen HP, Epema AH, Henning RH et al. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology. 1996; 84:397-403. (Pubitemid 26053841)
99. American Society of Anesthesiologists. ASA physical status classification system. www.asahq.org/for-members/clinical-information/asa-physical-status- classification-system.aspx (accessed 2010 Nov 16).
100. Conti G, Dell'Utri D, Vilardi V et al. Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients. Acta Anaesthesiol Scand. 1993; 37:105-9. (Pubitemid 23014666)
101. Sagarin MJ, Barton ED, Chung YM et al. Airway management by US and Canadian emergency medicine residents: a multicenter analysis of more than 6,000 endotracheal intubation attempts. Ann Emerg Med. 2005; 35:328-36. (Pubitemid 41362562)
102. Succinylcholine chloride package insert. Lake Forest, IL: Hospira, Inc.; 2004.
103. Allan W. Pathogenesis of myasthenia gravis. www.uptodate.com/contents/ pathogenesis-of-myasthenia-gravis (accessed 2011 Apr 7).
104. Caro DA, Laurin EG. Neuromuscular blocking agents. In: Walls RM, Murphy MF, eds. Manual of emergency airway management. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008:248-62.
105. Litman RS. Susceptibility to malignant hyperthermia. www.uptodate.com/ contents/susceptibility-to-malignanthyperthermia (accessed 2011 Apr 7).
106. Weintraub HD, Heisterkamp DV, Cooperman LH. Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man. Br J Anaesth. 1969; 41:1048-52.
107. List WF. Serum potassium changes during induction of anaesthesia. Br J Anaesth. 1967; 39:480-4.
108. Gronert GA. Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology. 2001; 94:523-9. (Pubitemid 32198464)
109. Cunningham AJ, Barry P. Intraocular pressure - physiology and implications for anesthetic management. Can Anaesth Soc J. 1986; 33:195-208. (Pubitemid 16110869)
110. Vachon CA, Warner DO, Bacon DR. Succinylcholine and the open globe: tracing the teaching. Anesthesiology. 2003; 99:220-4.
111. Naguib M, Samarkandi AH, El-Din ME et al. The dose of succinylcholine required for excellent endotracheal intubating conditions. Anesth Analg. 2006; 102:151-5. (Pubitemid 43038299)
112. Naguib M, Samarkandi AH, El-Din ME et al. Optimal dose of succinylcholine revisited. Anesthesiology. 2003; 99:1045-9. (Pubitemid 37339445)
113. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapidsequence induction of anesthesia in adult patients. Anesthesiology. 1993; 79:913-8. (Pubitemid 23339048)
114. Schreiber JU, Lysakowski C, Fuchs-Buder T et al. Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials. Anesthesiology. 1996; 85:231-9.
115. Donati F. The right dose of succinylcholine. Anesthesiology. 2003; 99:1037-8. (Pubitemid 37339441)
116. Cook DR. Newborn anaesthesia: pharmacological considerations. Can Anaesth Soc J. 1986; 3(suppl 1):S38-42.
117. Sutherland GA, Bevan JC, Bevan DR et al. Neuromuscular blockade in infants following intramuscular succinylcholine in two or five percent concentration. Can Anaesth Soc J. 1983; 30:342-6. (Pubitemid 13032563)
118. Rocuronium bromide package insert. Lake Forest, IL: Hospira, Inc.; 2008.
119. Vecuronium bromide package insert. Bedford, OH: Bedford Laboratories; 2004.
120. Walls RM. RSI using nondepolarizing agents. In: Walls RM, Murphy MF, eds. Manual of emergency airway management. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008:326-31.
121. Pancuronium bromide package insert. Irvine, CA: Teva Parenteral Medicines, Inc.; 2009.
122. Mallon WK, Keim SM, Shoenberger JM et al. Rocuronium vs succinylcholine in the emergency department: a critical appraisal. J Emerg Med. 2009; 37:183-8.
123. Sluga M, Ummenhofer W, Studer W et al. Rocuronium versus succinylcholine for rapid sequence induction of anesthesia and endotracheal intubation: a prospective, randomized trial in emergent cases. Anesth Analg. 2005; 101:1356-61. (Pubitemid 41531871)
124. McCourt KC, Salmela L, Mirakhur RK et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia. 1998; 53:867-71. (Pubitemid 28431593)
125. Laurin EG, Sakles JC, Panacek EA et al. A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. Acad Emerg Med. 2000; 7:1362-9.
126. Perry JJ, Lee JS, Sillberg VA et al. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008; 2:CD002788.
127. Kirkegaard-Nielson H, Caldwell JE, Berry PD. Rapid tracheal intubation with rocuronium: a probability approach to determining dose. Anesthesiology. 1999; 91:131-6. (Pubitemid 29307346)